Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for anorexia nervosa in young adults
2024-515163-63-00Phase 2Authorised
- Sponsor
- Region Skåne
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of psilocybin in anorexia nervosa (AN), sponsored by Region Skåne. Primary endpoint: Incidence of adverse events and serious adverse events. Planned start Dec 2025; status: authorised.
02
Drugs
psilocybin
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on 2024-515163-63-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515163-63-00.